Hemispheric Hypoperfusion in Immune Effector Cell-Associated Neurotoxicity Syndrome following Chimeric Antigen Receptor T-Cell Therapy
Ann Neurol
.
2024 Mar;95(3):617-619.
doi: 10.1002/ana.26832.
Epub 2023 Nov 29.
Authors
Nicolas Lambert
1
,
Julien Ly
1
,
Louis Deprez
2
,
Evelyne Willems
3
Affiliations
1
Department of Neurology, University Hospital of Liège, Liège, Belgium.
2
Department of Radiology, University Hospital of Liège, Liège, Belgium.
3
Department of Hematology, University Hospital of Liège, Liège, Belgium.
PMID:
37975425
DOI:
10.1002/ana.26832
No abstract available
MeSH terms
Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / adverse effects
Neurotoxicity Syndromes* / etiology
Receptors, Chimeric Antigen*
Substances
cell-associated neurotoxicity
Receptors, Chimeric Antigen